Fernández-Egea E - Search Results

1

Adaptation and validation of the Spanish version of the Strauss and Carpenter Prognostic Scale for Schizophrenia.

Ahuir M, Bernardo M, de la Serna E, Ochoa S, Carlson J, Escartín G, Gutiérrez-Zotes A, Valero J, Salamero M, Cañizares S, Fernández-Egea E, Cañete J, Gallo P. Ahuir M, et al. Rev Psiquiatr Salud Ment. 2009 Oct;2(4):150-9. doi: 10.1016/S1888-9891(09)73233-1. Epub 2010 Jan 25. Rev Psiquiatr Salud Ment. 2009. PMID: 23034344 English, Spanish.

2

[The structural stability of negative symptoms over time].

Wolpe N, Fernandez-Egea E. Wolpe N, et al. BJPsych Open. 2023 Nov 3;9(6):e208. doi: 10.1192/bjo.2023.600. BJPsych Open. 2023. PMID: 37920067 Free PMC article. French.

3

A new era for the negative symptoms of schizophrenia.

Fernandez-Egea E, Mucci A, Lee J, Kirkpatrick B. Fernandez-Egea E, et al. Br J Psychiatry. 2023 Jul;223(1):269-270. doi: 10.1192/bjp.2023.69. Epub 2023 Jul 10. Br J Psychiatry. 2023. PMID: 37424202

4

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia.

Sangüesa E, Fernández-Egea E, Concha J, García CB, Ribate MP. Sangüesa E, et al. Among authors: fernandez egea e. Biomedicines. 2024 Mar 7;12(3):597. doi: 10.3390/biomedicines12030597. Biomedicines. 2024. PMID: 38540209 Free PMC article.

5

Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.

Wolpe N, Chen S, Kirkpatrick B, Jones PB, Jenkins C, Cardinal RN, Fernandez-Egea E. Wolpe N, et al. Br J Psychiatry. 2023 Jul;223(1):336-337. doi: 10.1192/bjp.2023.84. Epub 2023 Jul 10. Br J Psychiatry. 2023. PMID: 37424199 No abstract available.

6

The longitudinal structure of negative symptoms in treatment resistant schizophrenia.

Wolpe N, Vituri A, Jones PB, Shahar M, Fernandez-Egea E. Wolpe N, et al. Compr Psychiatry. 2024 Jan;128:152440. doi: 10.1016/j.comppsych.2023.152440. Epub 2023 Nov 27. Compr Psychiatry. 2024. PMID: 38039918 Free article.

7

Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.

Wolpe N, Chen S, Kirkpatrick B, Jones PB, Jenkins C, Cardinal RN, Fernandez-Egea E. Wolpe N, et al. Br J Psychiatry. 2023 Jul;223(1):295-297. doi: 10.1192/bjp.2022.191. Br J Psychiatry. 2023. PMID: 36624935 Free PMC article.

8

Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.

Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hasan A; TRRIP Working Group. Wagner E, et al. Schizophr Bull. 2023 Jul 4;49(4):962-972. doi: 10.1093/schbul/sbad030. Schizophr Bull. 2023. PMID: 36943247 Free PMC article.

9

[Adaptation and validation into Spanish of Schedule for the Deficit Syndrome].

Bernardo M, Fernández-Egea E, Torras A, Gutiérrez F, Ahuir M, Arango C. Bernardo M, et al. Med Clin (Barc). 2007 Jun 16;129(3):91-3. doi: 10.1157/13107363. Med Clin (Barc). 2007. PMID: 17594858 Spanish.

10

Cannabis use and age of diagnosis of schizophrenia.

Sugranyes G, Flamarique I, Parellada E, Baeza I, Goti J, Fernandez-Egea E, Bernardo M. Sugranyes G, et al. Eur Psychiatry. 2009 Jun;24(5):282-6. doi: 10.1016/j.eurpsy.2009.01.002. Epub 2009 Mar 25. Eur Psychiatry. 2009. PMID: 19324529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters